11 research outputs found

    Detection of quantitative trait loci for growth and fatness in pigs

    Get PDF
    A quantitative trait locus (QTL) analysis of growth and fatness data from a three-generation experimental cross between Meishan (MS) and Large White (LW) pig breeds is presented. Six boars and 23 F1 sows, the progeny of six LW boars and six MS sows, produced 530 F2 males and 573 F2 females. Nine growth traits, i.e. body weight at birth and at 3, 10, 13, 17 and 22 weeks of age, average daily gain from birth to 3 weeks, from 3 to 10 weeks and from 10 to 22 weeks of age, as well as backfat thickness at 13, 17 and 22 weeks of age and at 40 and 60 kg live weight were analysed. Animals were typed for a total of 137 markers covering the entire porcine genome. Analyses were performed using two interval mapping methods: a line-cross (LC) regression method where founder lines were assumed to be fixed for different QTL alleles and a half-/full-sib (HFS) maximum likelihood method where allele substitution effects were estimated within each half-/full-sib family. Both methods revealed highly significant gene effects for growth on chromosomes 1, 4 and 7 and for backfat thickness on chromosomes 1, 4, 5, 7 and X, and significant gene effects on chromosome 6 for growth and backfat thickness. Suggestive QTLs were also revealed by both methods on chromosomes 2 and 3 for growth and 2 for backfat thickness. Significant gene effects were detected for growth on chromosomes 11, 13, 14, 16 and 18 and for backfat thickness on chromosome 8, 10, 13 and 14. LW alleles were associated with high growth rate and low backfat thickness, except for those of chromosome 7 and to a lesser extent early-growth alleles on chromosomes 1 and 2 and backfat thickness alleles on chromosome 6

    Strategy for the management of diabetic macular edema: the European Vitreo-Retinal Society macular edema study

    Get PDF
    Objective. To compare the efficacy of different therapies in the treatment of diabetic macular edema (DME). Design. Nonrandomized, multicenter clinical study. Participants. 86 retina specialists from 29 countries provided clinical information on 2,603 patients with macular edema including 870 patients with DME. Methods. Reported data included the type and number of treatment(s) performed, the pre-and posttreatment visual acuities, and other clinical findings.The results were analyzed by the French INSEE (National Institute of Statistics and Economic Studies). Main Outcome Measures. Mean change of visual acuity and mean number of treatments performed. Results.The change in visual acuity over time in response to each treatment was plotted in second order polynomial regression trend lines. Intravitreal triamcinolone monotherapy resulted in some improvement in vision. Treatmentwith threshold or subthreshold grid laser also resulted in minimal vision gain. Anti-VEGF therapy resulted in more significant visual improvement. Treatment with pars plana vitrectomy and internal limiting membrane (ILM) peeling alone resulted in an improvement in vision greater than that observed with anti-VEGF injection alone. In our DME study, treatment with vitrectomy and ILM peeling alone resulted in the better visual improvement compared to other therapies

    Apports actuels et futurs des marqueurs gĂ©nĂ©tiques dans l’amĂ©lioration des populations animales. Les contrĂŽles de filiation dans les populations

    No full text
    Le contrĂŽle de filiation est utilisĂ© par les organismes en charge de l’amĂ©lioration gĂ©nĂ©tique des espĂšces d’élevage. Il permet de contrĂŽler l’exactitude des gĂ©nĂ©alogies enregistrĂ©es dans les fichiers des chaĂźnes nationales d’identification. Il est rĂ©alisĂ© en comparant les hĂ©motypes des trois membres (pĂšre, mĂšre, produit) des familles contrĂŽlĂ©es. Les analyses comportent un grand nombre de tests immunologiques et biochimiques confĂ©rant au contrĂŽle de filiation une grande efficacitĂ© dans la dĂ©tection des familles erronĂ©es

    Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study

    No full text
    Objective. To compare the efficacy of different therapies in the treatment of diabetic macular edema (DME). Design. Nonrandomized, multicenter clinical study. Participants. 86 retina specialists from 29 countries provided clinical information on 2,603 patients with macular edema including 870 patients with DME. Methods. Reported data included the type and number of treatment(s) performed, the pre- and posttreatment visual acuities, and other clinical findings. The results were analyzed by the French INSEE (National Institute of Statistics and Economic Studies). Main Outcome Measures. Mean change of visual acuity and mean number of treatments performed. Results. The change in visual acuity over time in response to each treatment was plotted in second order polynomial regression trend lines. Intravitreal triamcinolone monotherapy resulted in some improvement in vision. Treatment with threshold or subthreshold grid laser also resulted in minimal vision gain. Anti-VEGF therapy resulted in more significant visual improvement. Treatment with pars plana vitrectomy and internal limiting membrane (ILM) peeling alone resulted in an improvement in vision greater than that observed with anti-VEGF injection alone. In our DME study, treatment with vitrectomy and ILM peeling alone resulted in the better visual improvement compared to other therapies

    Utilisation de marqueurs génétiques en sélection : les activités de Labogena

    No full text
    National audienceLe diagnostic gĂ©nĂ©tique appliquĂ© Ă  la sĂ©lection animale n’est pas rĂ©cent, mais des progrĂšs fantastiques ont Ă©tĂ© rĂ©alisĂ©s ces derniĂšres annĂ©es grĂące Ă  l’émergence des techniques de biologie molĂ©culaire. L’évolution du nombre d’analyses rĂ©alisĂ©es par LABOGENA, 45 000 en 1988 pour plus de 100 000 en 1998, est bien la preuve de cet essor. Si deux tiers des activitĂ©s demeurent traditionnelles, 30 % sont rĂ©alisĂ©es grĂące aux marqueurs de l’ADN et la tendance va encore s’accentuer. La biologie molĂ©culaire permet de rĂ©aliser des progrĂšs et d’augmenter les possibilitĂ©s de diagnostic : les supports biologiques utilisables sont nombreux (sang, poil, peau, viande, embryon, sperme 
) ; l’émergence de nouveaux marqueurs polymorphes comme les marqueurs microsatellites de l’ADN permet l’identification et le contrĂŽle de filiations pour de nouvelles espĂšces (Porc, Chien, Turbot 
) ; les diagnostics peuvent ĂȘtre rĂ©alisĂ©s trĂšs prĂ©cocement par l’analyse directe des variations des gĂšnes impliquĂ©s (exemple de la qualitĂ© fromagĂšre du lait dĂ©terminĂ©e sur les futurs reproducteurs mĂąles) ; les pathologies d’origine gĂ©nĂ©tique peuvent ĂȘtre recherchĂ©es par les mutations causales (hyperthermie maligne, tremblante 
). Ces informations sur les gĂ©notypes aident les sĂ©lectionneurs Ă  dĂ©finir leurs stratĂ©gies et permettent d’assurer une bonne gestion des reproducteurs et des populations animales
    corecore